Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycopyrronium and Indacaterol Effects on Methacholine Dose-response in Asthma
NCT02953041Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Oct 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glycopyrronium, indacaterol in asthma, sponsored by University of Saskatchewan. Started Oct 2016; status: completed.
02
Drugs
glycopyrroniumindacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02953041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953041.